Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States

IF 12 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Clinical Gastroenterology and Hepatology Pub Date : 2022-10-01 DOI:10.1016/j.cgh.2022.05.045
Donghee Kim , Omar Alshuwaykh , Brittany B. Dennis , George Cholankeril , Aijaz Ahmed
{"title":"Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States","authors":"Donghee Kim ,&nbsp;Omar Alshuwaykh ,&nbsp;Brittany B. Dennis ,&nbsp;George Cholankeril ,&nbsp;Aijaz Ahmed","doi":"10.1016/j.cgh.2022.05.045","DOIUrl":null,"url":null,"abstract":"<div><h3>Background &amp; Aims</h3><p>During the global coronavirus disease 2019 (COVID-19) pandemic, patients with pre-existing chronic liver disease may represent a vulnerable population. We studied the etiology-based temporal trends in mortality of chronic liver disease and the underlying cause of death in the United States before and during the COVID-19 pandemic.</p></div><div><h3>Methods</h3><p>Population-based analyses were performed on United States national mortality records (2017–2020). Temporal trends in quarterly age-standardized mortality were obtained by joinpoint analysis with estimates of quarterly percentage change (QPC).</p></div><div><h3>Results</h3><p>Quarterly age-standardized all-cause mortality due to alcohol-related liver disease (ALD) initially increased at a quarterly rate of 1.1% before the COVID-19 pandemic, followed by a sharp increase during the COVID-19 pandemic at a quarterly rate of 11.2%. Likewise, steady increase in mortality of nonalcoholic fatty liver disease before the COVID-19 pandemic (QPC, 1.9%) accelerated during the COVID-19 pandemic (QPC, 6.6%). Although ALD-related mortality increased steeply compared with viral hepatitis-related mortality during the COVID-19 pandemic, the proportion of mortality due to COVID-19 among individuals with ALD was the lowest at 2.5%; more than 50% lower than viral hepatitis. The significant decline in all-cause mortality due to viral hepatitis before the COVID-19 pandemic plateaued during the COVID-19 pandemic due to increase in COVID-19-related mortality in individuals with viral hepatitis. Mortality due to cirrhosis increased markedly during the COVID-19 pandemic, mainly attributable to ALD.</p></div><div><h3>Conclusion</h3><p>All-cause mortality for ALD and nonalcoholic fatty liver disease rapidly accelerated during the COVID-19 pandemic compared with the pre-COVID-19 era. There has been a significant decline in viral hepatitis; however, a significant increase in COVID-related death in this population.</p></div>","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":"20 10","pages":"Pages 2307-2316.e3"},"PeriodicalIF":12.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262655/pdf/","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1542356522006024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 14

Abstract

Background & Aims

During the global coronavirus disease 2019 (COVID-19) pandemic, patients with pre-existing chronic liver disease may represent a vulnerable population. We studied the etiology-based temporal trends in mortality of chronic liver disease and the underlying cause of death in the United States before and during the COVID-19 pandemic.

Methods

Population-based analyses were performed on United States national mortality records (2017–2020). Temporal trends in quarterly age-standardized mortality were obtained by joinpoint analysis with estimates of quarterly percentage change (QPC).

Results

Quarterly age-standardized all-cause mortality due to alcohol-related liver disease (ALD) initially increased at a quarterly rate of 1.1% before the COVID-19 pandemic, followed by a sharp increase during the COVID-19 pandemic at a quarterly rate of 11.2%. Likewise, steady increase in mortality of nonalcoholic fatty liver disease before the COVID-19 pandemic (QPC, 1.9%) accelerated during the COVID-19 pandemic (QPC, 6.6%). Although ALD-related mortality increased steeply compared with viral hepatitis-related mortality during the COVID-19 pandemic, the proportion of mortality due to COVID-19 among individuals with ALD was the lowest at 2.5%; more than 50% lower than viral hepatitis. The significant decline in all-cause mortality due to viral hepatitis before the COVID-19 pandemic plateaued during the COVID-19 pandemic due to increase in COVID-19-related mortality in individuals with viral hepatitis. Mortality due to cirrhosis increased markedly during the COVID-19 pandemic, mainly attributable to ALD.

Conclusion

All-cause mortality for ALD and nonalcoholic fatty liver disease rapidly accelerated during the COVID-19 pandemic compared with the pre-COVID-19 era. There has been a significant decline in viral hepatitis; however, a significant increase in COVID-related death in this population.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
美国COVID-19大流行之前和期间慢性肝病病因学死亡率的趋势
背景,在2019年全球冠状病毒病(COVID-19)大流行期间,既往存在慢性肝病的患者可能是弱势群体。我们研究了美国在COVID-19大流行之前和期间慢性肝病死亡率的病因学时间趋势和潜在死亡原因。方法对2017-2020年美国全国死亡率记录进行基于人群的分析。通过结合季度百分比变化(QPC)估算,获得季度年龄标准化死亡率的时间趋势。结果酒精相关性肝病(ALD)年龄标准化全因死亡率在2019冠状病毒病(COVID-19)大流行前以每季度1.1%的速度上升,在2019冠状病毒病大流行期间以每季度11.2%的速度急剧上升。同样,在COVID-19大流行之前(QPC, 1.9%),非酒精性脂肪性肝病的死亡率稳步上升,在COVID-19大流行期间(QPC, 6.6%)加速上升。尽管在COVID-19大流行期间,与病毒性肝炎相关的死亡率相比,ALD相关的死亡率急剧上升,但ALD患者因COVID-19导致的死亡率比例最低,为2.5%;比病毒性肝炎低50%以上。由于病毒性肝炎患者中与COVID-19相关的死亡率增加,在COVID-19大流行之前病毒性肝炎全因死亡率的显著下降在COVID-19大流行期间达到了顶峰。在COVID-19大流行期间,肝硬化死亡率显著增加,主要归因于ALD。结论与COVID-19前相比,COVID-19大流行期间ALD和非酒精性脂肪性肝病的全因死亡率迅速增加。病毒性肝炎的发病率显著下降;然而,这一人群中与covid相关的死亡人数显著增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
16.90
自引率
4.80%
发文量
903
审稿时长
22 days
期刊介绍: Clinical Gastroenterology and Hepatology (CGH) is dedicated to offering readers a comprehensive exploration of themes in clinical gastroenterology and hepatology. Encompassing diagnostic, endoscopic, interventional, and therapeutic advances, the journal covers areas such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion. As a peer-reviewed publication, CGH features original articles and scholarly reviews, ensuring immediate relevance to the practice of gastroenterology and hepatology. Beyond peer-reviewed content, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Multimedia elements, including images, video abstracts, and podcasts, enhance the reader's experience. CGH remains actively engaged with its audience through updates and commentary shared via platforms such as Facebook and Twitter.
期刊最新文献
Psychometric Development and Internal Validation of a Short Version of the Crohn’s Anal Fistula Quality of Life Scale Assessing predictive performance of FIB-4 in settings with lower prevalence of liver fibrosis Baked and Limited Regular Milk is Tolerated in Adults with Milk-Triggered Eosinophilic Esophagitis: A Prospective Pilot Study Randomized Controlled Trial of Upper Esophageal Sphincter Assist Device in Laryngopharyngeal Reflux Disease Open-label, phase 2a pilot study evaluating the efficacy and tolerability of topical mesalamine treatment in adult patients with active eosinophilic esophagitis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1